Switch to: References

Add citations

You must login to add citations.
  1. Personalised Medicine: A Critique on the Future of Health Care. [REVIEW]Jacqueline Savard - 2013 - Journal of Bioethical Inquiry 10 (2):197-203.
    In recent years we have seen the emergence of “personalised medicine.” This development can be seen as the logical product of reductionism in medical science in which disease is increasingly understood in molecular terms. Personalised medicine has flourished as a consequence of the application of neoliberal principles to health care, whereby a commercial and social need for personalised medicine has been created. More specifically, personalised medicine benefits from the ongoing commercialisation of the body and of genetic knowledge, the idea that (...)
    Direct download (8 more)  
     
    Export citation  
     
    Bookmark   4 citations  
  • Alter Wein in Neuen Schläuchen? Ethische Implikationen der Individualisierten MedizinOld Wine in New Bottles? Ethical Implications of Individualized Medicine.Sebastian Schleidgen & Georg Marckmann - 2013 - Ethik in der Medizin 25 (3):223-231.
    Die sogenannte individualisierte Medizin (IM) ist in den letzten Jahren zu einem Schlagwort in Wissenschaft, Politik und Öffentlichkeit geworden. Wie jede technologische Neuentwicklung hat sie jedoch (potentielle) ethische Implikationen, die es zu berücksichtigen gilt, um eine angemessene Entwicklung und Anwendung individualisierter Präventions- und Therapiemaßnahmen zu ermöglichen. Allerdings steht eine ethische Bewertung der IM vor verschiedenen methodischen Herausforderungen, die sich insbesondere aus der Heterogenität des Problembereichs, begrifflicher Unklarheit sowie dem Frühstadium ihrer Entwicklung ergeben. Der vorliegende Beitrag spezifiziert zunächst den Begriff der (...)
    No categories
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  • Database Research: Public and Private Interests.Vilhjálmur Árnason - 2011 - Cambridge Quarterly of Healthcare Ethics 20 (4):563-571.
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   5 citations  
  • Re-Focusing the Ethical Discourse on Personalized Medicine: A Qualitative Interview Study with Stakeholders in the German Healthcare System.Sebastian Schleidgen & Georg Marckmann - 2013 - BMC Medical Ethics 14 (1):20.
    In recent years, personalized medicine (PM) has become a highly regarded line of development in medicine. Yet, it is still a relatively new field. As a consequence, the discussion of its future developments, in particular of its ethical implications, in most cases can only be anticipative. Such anticipative discussions, however, pose several challenges. Nevertheless, they play a crucial role for shaping PM’s further developments. Therefore, it is vital to understand how the ethical discourse on PM is conducted, i.e. on what (...)
    Direct download (15 more)  
     
    Export citation  
     
    Bookmark   4 citations  
  • The Promise of Pharmacogenetics: Assessing the Prospects for Disease and Patient Stratification.Andrew Smart & Paul Martin - 2006 - Studies in History and Philosophy of Science Part C 37 (3):583-601.
    Pharmacogenetics is an emerging biotechnology concerned with understanding the genetic basis of drug response, and promises to transform the development, marketing and prescription of medicines. This paper is concerned with analysing the move towards segmented drug markets, which is implicit in the commercial development of pharmacogenetics. It is claimed that in future who gets a particular drug will be determined by their genetic make up. Drawing on ideas from the sociology of expectations we examine how pharmaceutical and biotechnology companies are (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  • Of Nanochips and Persons: Toward an Ethics of Diagnostic Technology in Personalized Medicine. [REVIEW]Sophie Pellé & Vanessa Nurock - 2012 - NanoEthics 6 (3):155-165.
    This paper proposes an ethical reflection on personalized medicine and more precisely on the diagnostic technology underlying it, including nanochips. Our approach is inspired by a combination of two philosophical frames of reference: first, John Dewey’s distinction between intuitive valuation and reflexive evaluation, second, John Rawls’ reflective equilibrium. We aim at what we call a ‘reflexive equilibrium’, a mutual adjustment between on the one hand, the intuitive beliefs scientists have about the ethics of the technologies they work on (‘valuations’ in (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  • Is Racial Profiling More Benign in Medicine Than Law Enforcement?David Wasserman - 2011 - The Journal of Ethics 15 (1-2):119 - 129.
    It might seem that racial profiling by doctors raised few of the same concerns as racial profiling by police, immigration, or airport security. This paper argues that the similarities are greater than first appear. The inappropriate use of racial generalizations by doctors may be as harmful and insulting as their use by law enforcement officials. Indeed, the former may be more problematic in compromising an ideal of individualized treatment that is more applicable to doctors than to police. Yet doctors, unlike (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  • Between Hype and Hope: What is Really at Stake with Personalized Medicine?Camille Abettan - 2016 - Medicine, Health Care and Philosophy 19 (3):423-430.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  • Ethics and Nanopharmacy: Value Sensitive Design of New Drugs. [REVIEW]Job Timmermans, Yinghuan Zhao & Jeroen van den Hoven - 2011 - NanoEthics 5 (3):269-283.
    Although applications are being developed and have reached the market, nanopharmacy to date is generally still conceived as an emerging technology. Its concept is ill-defined. Nanopharmacy can also be construed as a converging technology, which combines features of multiple technologies, ranging from nanotechnology to medicine and ICT. It is still debated whether its features give rise to new ethical issues or that issues associated with nanopharma are merely an extension of existing issues in the underlying fields. We argue here that, (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   7 citations